NUTX Director Scott J. Saunders Receives 603 Shares (RSU Conversion)

What Happened

• Scott J. Saunders, a director of Nutex Health, acquired 603 shares of common stock on July 31, 2026 through the conversion/exercise of a derivative (code M). The reported per-share price was $0.00, so no cash was paid; total reported purchase value is $0.
• This was a conversion of restricted stock units (RSUs) into common stock (see footnote). This is not an open-market purchase or sale — it reflects settlement/vesting of previously granted equity.

Key Details

• Transaction date: 2026-07-31; Filing date: 2026-08-03 (Form 4 filed within the usual two-business-day window following the transaction).
• Shares acquired: 603 at $0.00 per share; total reported cash paid: $0.
• Footnote: RSUs convert into common stock on a one-for-one basis.
• Shares owned after the transaction: not specified in the provided filing extract.
• Transaction code: M (exercise or conversion of derivative). No indication of an immediate sale or tax-withholding shares in this filing.

Context

• This was a conversion/settlement of previously granted RSUs into common stock, a routine insider event tied to compensation/vesting rather than an expression of a market view. There is no evidence in this filing that the shares were sold immediately.